Changes in income and employment after diagnosis among patients with multiple myeloma in The Netherlands
-
Published:2024-09
Issue:9
Volume:24
Page:604-610
-
ISSN:2152-2650
-
Container-title:Clinical Lymphoma Myeloma and Leukemia
-
language:en
-
Short-container-title:Clinical Lymphoma Myeloma and Leukemia
Author:
Bennink ChristineORCID,
Brink Mirian,
Duijts Saskia F.A.,
Scheurer Hans,
Sonneveld Pieter,
Blommestein Hedwig M.
Reference32 articles.
1. Het multipel myeloom in Nederland, 2014-2017;Brink;Integraal Kankercentrum Nederland (IKNL),2020
2. Decrease in early mortality for newly diagnosed multiple myeloma patients in the Netherlands: a population-based study;Brink;Blood Cancer J,2021
3. Outcomes of autologous stem cell transplantation for multiple myeloma in Saudi Arabia;Abdrabou;Ann Saudi Med,2021
4. Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study
5. Triplet therapy, transplantation, and maintenance until progression in myeloma;Richardson;N Engl J Med,2022